What is Bromantane (non-peptide)?

A Russian adamantane-derived stimulant and anxiolytic (Ladasten), sold alongside nootropic peptides; not a peptide.

Bromantane (non-peptide) in the library · · Human Trials · What are peptides?

0 registered trials · 9 indexed papers

From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.

What it is

Bromantane is described as a small molecule registered in Russia as Ladasten for asthenia (fatigue and weakness).

Mechanism (as described)

  • It is described as increasing dopamine synthesis gradually rather than releasing it acutely.

Evidence (as described)

  • Russian placebo-controlled studies in neurasthenia reported benefit (Neznamov et al., 2009, 2012). It is banned in sport.

Status

Registered in Russia; not approved elsewhere.

Peer-reviewed studies (9)

PaperAuthorsJournalYearType
[Optimization of pharmacological therapy for weakness syndrome in incurable patients]Ryazankina AA et al.Voprosy onkologii2015Controlled Clinical Trial
[Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types]Neznamov GG et al.Eksperimental'naia i klinicheskaia farmakologiia2012Randomized Controlled Trial
[Self-evaluation of single test doses and objective indices of ladasten vs. placebo efficacy in neurasthenic patients]Reutova MA et al.Eksperimental'naia i klinicheskaia farmakologiia2011Randomized Controlled Trial
[Ladasten in the management of non-motor symptoms of Parkinson's disease]Sarycheva TN et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2011Randomized Controlled Trial
[Prospects for using ladasten preparations in patients with irritable bowel syndrome]Uspenskiĭ IuP et al.Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology2010Clinical Trial
[Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]Voznesenskaia TG et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2010Clinical Trial
[Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2010Clinical Trial
[Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]Neznamov GG et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2009Randomized Controlled Trial
[Pilot clinical trial of ladasten]Siuniakov SA et al.Eksperimental'naia i klinicheskaia farmakologiia2006Clinical Trial, Phase II

Conditions researched

Related compounds

FAQ

What is Bromantane (non-peptide)?

A Russian adamantane-derived stimulant and anxiolytic (Ladasten), sold alongside nootropic peptides; not a peptide.

How many registered human trials study Bromantane (non-peptide)?

The PeptideWhiz trial index lists 0 registered trials for Bromantane (non-peptide).

How much published research exists on Bromantane (non-peptide)?

The PeptideWhiz paper index links 9 PubMed papers to Bromantane (non-peptide).

Which conditions is Bromantane (non-peptide) researched for?

Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers, Parkinson's disease.

Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).